Achatz, S.;Jarasch, A.;Skerra, A.Structural plasticity in the loop region of engineered lipocalins with novel ligand specificities, so-called AnticalinsJ Struct Biol X20226100054
Albrecht, V.;Richter, A.;Pfeiffer, S.;Gebauer, M.;Lindner, S.;Gieser, E.;Schuller, U.;Schichor, C.;Gildehaus, F. J.;Bartenstein, P.;Tonn, J. C.;Skerra, A.;Glass, R.Anticalins directed against the fibronectin extra domain B as diagnostic tracers for glioblastomasInt J Cancer201613851269-80
Barinka, C.;Ptacek, J.;Richter, A.;Novakova, Z.;Morath, V.;Skerra, A.Selection and characterization of Anticalins targeting human prostate-specific membrane antigen (PSMA)Protein Eng Des Sel2016293105-15
Barkovskiy, M.;Ilyukhina, E.;Dauner, M.;Eichinger, A.;Skerra, A.An engineered lipocalin that tightly complexes the plant poison colchicine for use as antidote and in bioanalytical applicationsBiol Chem20194003351-366
Binder, U.;Skerra, A.PASylated thymosin α1: A long-acting immunostimulatory peptide for applications in oncology and virologyInt J Mol Sci2020221
Binder, Uli;Skerra, ArnePASylation®: A versatile technology to extend drug deliveryCurr Opin Colloid Interface Sci20173110-17
Bolz, C.;Bach, N. C.;Meyer, H.;Muller, G.;Dawidowski, M.;Popowicz, G.;Sieber, S. A.;Skerra, A.;Gerhard, M.Comparison of enzymatic properties and small molecule inhibition of γ-glutamyltranspeptidases from pathogenic and commensal bacteriaBiol Chem20173983341-357
Bolze, F.;Bast, A.;Mocek, S.;Morath, V.;Yuan, D.;Rink, N.;Schlapschy, M.;Zimmermann, A.;Heikenwalder, M.;Skerra, A.;Klingenspor, M.Treatment of diet-induced lipodystrophic C57BL/6J mice with long-acting PASylated leptin normalises insulin sensitivity and hepatic steatosis by promoting lipid utilisationDiabetologia20165992005-12
Bolze, F.;Morath, V.;Bast, A.;Rink, N.;Schlapschy, M.;Mocek, S.;Skerra, A.;Klingenspor, M.Long-acting PASylated leptin ameliorates obesity by promoting satiety and preventing hypometabolism in leptin-deficient Lep(ob/ob) miceEndocrinology20161571233-44
Breibeck, J.;Skerra, A.The polypeptide biophysics of proline/alanine-rich sequences (PAS): Recombinant biopolymers with PEG-like propertiesBiopolymers20181091e23069